Congenital, profound, non-progressive sensorineural hearing loss caused by biallelic loss-of-function variants in RIPOR2 (formerly FAM65B). It is a disease of one small place: RIPOR2 forms a ring of oligomers around the basal taper of hair cell stereocilia, the narrow hinge where each stereocilium pivots when sound deflects the bundle. Remove it and stereocilia still start to grow, but the taper compartment loses its organisation, mechanotransduction fails, and the bundle deteriorates. The entry has two features that shaped how it is curated. The first is that RIPOR2 causes two different hearing-loss diseases, and they are easy to conflate. This one is recessive, congenital, profound and stable. A heterozygous in-frame deletion in the same gene causes an adult-onset, progressive, dominant hearing loss that is a common founder allele in the Netherlands. The deletion is not a milder version of this disease and evidence about it is not curated here; it appears under differential diagnoses instead. The second is a model mismatch that the field has stated explicitly. The Tunisian siblings with a homozygous nonsense allele have vestibular areflexia alongside their deafness, while the Ripor2 knockout mouse and a zebrafish model are deaf with normal vestibular function. The mouse is the source of nearly everything known about the mechanism, so the discrepancy matters, and it is recorded as a HUMAN_MODEL_MISMATCH rather than left as a footnote.
Ask a research question about Autosomal Recessive Nonsyndromic Hearing Loss 104. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from Autosomal Recessive Nonsyndromic Hearing Loss 104:
name: Autosomal Recessive Nonsyndromic Hearing Loss 104
creation_date: "2026-08-26T14:00:00Z"
category: Mendelian
disease_term:
preferred_term: autosomal recessive nonsyndromic hearing loss 104
term:
id: MONDO:0014675
label: autosomal recessive nonsyndromic hearing loss 104
synonyms:
- DFNB104
- deafness, autosomal recessive 104
- RIPOR2-related autosomal recessive nonsyndromic hearing loss
- FAM65B-related deafness
description: >-
Congenital, profound, non-progressive sensorineural hearing loss caused by biallelic
loss-of-function variants in RIPOR2 (formerly FAM65B). It is a disease of one small
place: RIPOR2 forms a ring of oligomers around the basal taper of hair cell stereocilia,
the narrow hinge where each stereocilium pivots when sound deflects the bundle. Remove
it and stereocilia still start to grow, but the taper compartment loses its
organisation, mechanotransduction fails, and the bundle deteriorates.
The entry has two features that shaped how it is curated.
The first is that RIPOR2 causes two different hearing-loss diseases, and they are easy
to conflate. This one is recessive, congenital, profound and stable. A heterozygous
in-frame deletion in the same gene causes an adult-onset, progressive, dominant hearing
loss that is a common founder allele in the Netherlands. The deletion is not a milder
version of this disease and evidence about it is not curated here; it appears under
differential diagnoses instead.
The second is a model mismatch that the field has stated explicitly. The Tunisian
siblings with a homozygous nonsense allele have vestibular areflexia alongside their
deafness, while the Ripor2 knockout mouse and a zebrafish model are deaf with normal
vestibular function. The mouse is the source of nearly everything known about the
mechanism, so the discrepancy matters, and it is recorded as a HUMAN_MODEL_MISMATCH
rather than left as a footnote.
parents:
- Autosomal Recessive Nonsyndromic Hearing Loss
- Hereditary Hearing Loss
prevalence:
- population: Worldwide
measure_type: CASES_IN_LITERATURE
prevalence_class: NOT_YET_DOCUMENTED
notes: >-
Two consanguineous families are reported: a large Turkish kindred with six affected
individuals homozygous for a splice-acceptor allele, and a Tunisian sibship of three
homozygous for a nonsense allele. Each allele is private to its family. No prevalence
estimate exists, and none is meaningful at this evidence base.
evidence:
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In a large consanguineous Turkish kindred with recessive nonsyndromic, prelingual,
profound hearing loss, we identified in the gene FAM65B (MIM611410) a splice site
mutation (c.102-1G>A) that perfectly cosegregates with the phenotype in the family.
explanation: >-
The first family and the cosegregation on which the gene-disease claim rests.
pathophysiology:
- name: Biallelic RIPOR2 Loss-of-Function Variant
role: trigger
biological_scale: MOLECULAR
description: >-
Two reported alleles, in two consanguineous families, both loss of function and both
homozygous.
The Turkish allele c.102-1G>A destroys a splice acceptor site, causing exon skipping
and an in-frame deletion of 52 residues from the PX membrane-localization domain. It
is not a null: protein is made, but it is the wrong protein, and where it goes is the
point of the next node.
The Tunisian allele c.1561C>T (p.Arg521*) is a nonsense variant. It is the allele that
comes with a vestibular phenotype, which the splice allele does not.
genetic_context:
gene:
preferred_term: RIPOR2
term:
id: hgnc:13872
label: RIPOR2
variant_origin: GERMLINE
zygosity: HOMOZYGOUS
functional_impact_category: LOSS_OF_FUNCTION
description: >-
Homozygous in both reported families, each of which is consanguineous. Typed
LOSS_OF_FUNCTION for both alleles: the splice allele's product fails to reach its
compartment and the nonsense allele truncates the protein.
downstream:
- target: Loss of RIPOR2 from the Stereociliary Taper
causal_link_type: DIRECT
description: >-
Either allele removes functional RIPOR2 from the place it works.
evidence:
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The mutation leads to exon skipping and deletion of 52-amino acid residues of a PX
membrane localization domain.
explanation: >-
The molecular consequence of the Turkish allele, and the domain it removes.
- reference: PMID:37864412
reference_title: "RIPOR2: A new gene of non-syndromic cochleovestibular dysfunction, discrepancy between human pathology and animal models."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
in RIPOR2 (RHO family interacting cell polarization regulator 2) has been identified
by WES in Tunisian siblings suffering from congenital bilateral profound hearing and
vestibular dysfunctions.
explanation: >-
The second family and its allele, together with the phenotype that distinguishes it.
- name: Loss of RIPOR2 from the Stereociliary Taper
role: central_effector
biological_scale: MOLECULAR
description: >-
RIPOR2 works at the plasma membrane of stereocilia, and specifically at their base. In
the mouse cochlea the wild-type protein localises to the stereociliary plasma membrane
of inner and outer hair cells, and super-resolution imaging places it as a
circumferential ring of oligomers around the basal taper - the narrow hinge where a
stereocilium pivots when the bundle is deflected.
The splice allele's product does not get there. Wild-type protein targets the plasma
membrane while the mutant accumulates in cytoplasmic inclusion bodies, so this is a
mislocalisation disease at the protein level rather than simple absence, even though
the functional outcome is the same.
cell_types:
- preferred_term: cochlear inner hair cell
term:
id: CL:0000589
label: cochlear inner hair cell
- preferred_term: cochlear outer hair cell
term:
id: CL:0000601
label: cochlear outer hair cell
cellular_components:
- preferred_term: stereocilium
term:
id: GO:0032420
label: stereocilium
locations:
- preferred_term: cochlea
term:
id: UBERON:0001844
label: cochlea
downstream:
- target: Disorganisation of the Taper Compartment
causal_link_type: DIRECT
description: >-
RIPOR2 oligomerisation organises the taper; without it the compartment's other
components are displaced.
evidence:
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
We show that wild-type Fam65b is expressed during embryonic and postnatal
development stages in murine cochlea, and that the protein localizes to the plasma
membranes of the stereocilia of inner and outer hair cells of the inner ear.
explanation: >-
Establishes where the protein is, in the cell types this disease affects.
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
The wild-type protein targets the plasma membrane, whereas the mutant protein
accumulates in cytoplasmic inclusion bodies and does not reach the membrane.
explanation: >-
The mislocalisation of the patient allele's product, which is the functional case
for calling the splice variant loss of function.
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Using biochemistry and stochastic optical reconstruction microscopy (STORM), we show
here that Fam65b oligomers form a circumferential ring near the basal taper of the
mechanically sensitive stereocilia of murine hair cells.
explanation: >-
Refines the localisation from "stereocilia" to the taper ring, which is what makes
the mechanism specific.
- name: Disorganisation of the Taper Compartment
role: central_effector
biological_scale: CELLULAR
mechanism_confidence: ESTABLISHED
description: >-
The taper is a distinct subcellular compartment with its own protein complement, and
RIPOR2 organises it. Two dependencies are documented in mouse.
Taperin, a second taper protein, forms a dense-core-like structure that is disrupted
when Fam65b is absent - so the compartment loses its architecture, not just one of its
components. And RIPOR2 is not self-organising: RhoC binds it, co-localises with it in
stereocilia and regulates its oligomerisation, and both the RhoC interaction and the
oligomerisation are required for function. That places the lesion in a small GTPase
module rather than in a structural protein acting alone.
All of this is mouse work. The claim curated here is about the mechanism, and the
human evidence for it is the phenotype plus the mislocalisation of the patient allele.
cell_types:
- preferred_term: sensory hair cell
term:
id: CL:0000855
label: sensory hair cell
cellular_components:
- preferred_term: stereocilium
term:
id: GO:0032420
label: stereocilium
biological_processes:
- preferred_term: Rho protein signal transduction
term:
id: GO:0007266
label: Rho protein signal transduction
- preferred_term: auditory receptor cell stereocilium organization
term:
id: GO:0060088
label: auditory receptor cell stereocilium organization
modifier: ABNORMAL
downstream:
- target: Hair Bundle Malformation and Misorientation
causal_link_type: DIRECT
description: >-
A disorganised taper gives a malformed bundle: stereocilia begin to develop and then
deteriorate, and bundle orientation is set wrongly during morphogenesis.
- target: Mechanotransduction Failure
causal_link_type: DIRECT
description: >-
The taper is where the stereocilium pivots, so its disorganisation affects
transduction directly and not only through the bundle's shape.
evidence:
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Taperin, a second protein near the taper, forms a dense-core-like structure that is
disrupted in the absence of Fam65b.
explanation: >-
The dependency that makes this a compartment-organisation defect rather than the
loss of one protein.
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
RhoC co-localizes with Fam65b in stereocilia and regulates Fam65b oligomerization.
explanation: >-
The upstream regulator of the ring, placing the mechanism in Rho GTPase signalling.
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Binding to RhoC and oligomerization are critical for Fam65b function.
explanation: >-
Establishes both dependencies as functionally required, not merely correlated.
- name: Hair Bundle Malformation and Misorientation
role: effector
biological_scale: CELLULAR
description: >-
Two distinct bundle defects follow, and they occur at different stages.
During morphogenesis, the absence of Ripor2 affects the orientation of the hair bundle.
The route runs through Myh9, the non-muscle myosin heavy chain encoded by a known
deafness gene: Ripor2 interacts with Myh9, and in its absence Myh9 protein is low in
the cochlea despite increased Myh9 transcript, while the kinocilium - which sets the
bundle's axis - is aberrantly placed and its phosphorylated Myh9 content reduced. The
transcript-protein discordance is the informative detail, because it makes this a
protein-stability effect rather than a transcriptional one.
After development, the bundle does not hold. Stereocilia of Fam65b-deficient hair
cells start to develop but then deteriorate - so this is a maintenance failure on top
of a morphogenetic one, and neither alone accounts for the phenotype.
cell_types:
- preferred_term: sensory hair cell
term:
id: CL:0000855
label: sensory hair cell
cellular_components:
- preferred_term: stereocilium bundle
term:
id: GO:0032421
label: stereocilium bundle
- preferred_term: kinocilium
term:
id: GO:0060091
label: kinocilium
downstream:
- target: Mechanotransduction Failure
causal_link_type: DIRECT
description: >-
A misoriented, deteriorating bundle cannot transduce deflection reliably.
evidence:
- reference: PMID:30280293
reference_title: "Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Here, we demonstrate that during the morphogenesis of the hair cell bundle, absence
of Ripor2 affects the orientation of this key subcellular structure.
explanation: >-
The morphogenetic half of this node.
- reference: PMID:30280293
reference_title: "Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Absence of Ripor2 is associated with low Myh9 abundance in the mouse cochlea despite
increased amount of Myh9 transcripts.
explanation: >-
The Myh9 route, with the transcript-protein discordance that identifies it as
post-transcriptional.
- reference: PMID:30280293
reference_title: "Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
In Ripor2-deficient mice, kinocilium shows an aberrant localization which associates
with a reduced content of phosphorylated Myh9.
explanation: >-
Links the misplaced kinocilium, which sets bundle orientation, to the Myh9 defect.
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Stereocilia of Fam65b-deficient murine hair cells start to develop, but
mechanotransduction is affected and stereocilia deteriorate.
explanation: >-
The maintenance half: development starts normally and the structure is then lost.
- name: Mechanotransduction Failure
role: effector
biological_scale: CELLULAR
description: >-
Hair cells lacking RIPOR2 fail to convert bundle deflection into a receptor current.
The failure is reported alongside, not after, the structural deterioration, which is
why it is drawn from both the taper node and the bundle node rather than only from the
structural one.
cell_types:
- preferred_term: cochlear inner hair cell
term:
id: CL:0000589
label: cochlear inner hair cell
- preferred_term: cochlear outer hair cell
term:
id: CL:0000601
label: cochlear outer hair cell
biological_processes:
- preferred_term: sensory perception of mechanical stimulus
term:
id: GO:0050954
label: sensory perception of mechanical stimulus
modifier: DECREASED
downstream:
- target: Congenital Profound Sensorineural Hearing Loss
causal_link_type: DIRECT
description: >-
No transduction current means no auditory signal, from birth.
- target: Vestibular End-Organ Dysfunction
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
Vestibular hair cells carry stereociliary bundles built on the same plan as cochlear
ones, so they are presumed to share the taper defect. That presumption is all this
edge is: the taper mechanism has been shown in cochlear hair cells only, no human
vestibular tissue has been examined, and the mouse and zebrafish models are
vestibularly normal despite being deaf. Typed with unknown intermediates for those
reasons, and see the model-mismatch discussion attached to the target node.
evidence:
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Our findings thus reveal a highly organized compartment near the base of stereocilia
that is critical for hair cell function and affected in disease.
explanation: >-
The paper's summary claim, connecting the taper compartment to hair cell function
and to this disease.
- name: Congenital Profound Sensorineural Hearing Loss
role: outcome
biological_scale: ORGANISM
description: >-
Bilateral, symmetric, profound, prelingual, and non-progressive. It is the constant
feature of the disease: present in all six affected members of the Turkish kindred and
all three Tunisian siblings.
locations:
- preferred_term: cochlea
term:
id: UBERON:0001844
label: cochlea
biological_processes:
- preferred_term: sensory perception of sound
term:
id: GO:0007605
label: sensory perception of sound
modifier: ABSENT
evidence:
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In a large consanguineous Turkish kindred with recessive nonsyndromic, prelingual,
profound hearing loss, we identified in the gene FAM65B (MIM611410) a splice site
mutation (c.102-1G>A) that perfectly cosegregates with the phenotype in the family.
explanation: >-
The phenotype in the first family: recessive, nonsyndromic, prelingual, profound.
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
We conclude that FAM65B is a plasma membrane-associated protein of hair cell
stereocilia that is essential for hearing.
explanation: >-
The gene-function conclusion that the hearing phenotype rests on.
- name: Vestibular End-Organ Dysfunction
role: outcome
biological_scale: ORGANISM
mechanism_confidence: PROVISIONAL
description: >-
Reported in one of the two families. The Tunisian siblings homozygous for p.Arg521*
have vestibular dysfunction alongside their deafness, while the Turkish kindred with
the splice allele had no balance problems.
Marked PROVISIONAL because with two families and two alleles it is not possible to
tell whether the difference is allele-specific, background-dependent, or an artefact
of how carefully vestibular function was assessed in the earlier family. The mouse
cannot arbitrate: it is deaf with normal vestibular function, which is curated as a
model mismatch rather than as evidence against the human finding.
locations:
- preferred_term: semicircular canal
term:
id: UBERON:0001840
label: semicircular canal
- preferred_term: internal ear
term:
id: UBERON:0001846
label: internal ear
evidence:
- reference: PMID:37864412
reference_title: "RIPOR2: A new gene of non-syndromic cochleovestibular dysfunction, discrepancy between human pathology and animal models."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
in RIPOR2 (RHO family interacting cell polarization regulator 2) has been identified
by WES in Tunisian siblings suffering from congenital bilateral profound hearing and
vestibular dysfunctions.
explanation: >-
The combined cochleovestibular phenotype in the family that has it.
phenotypes:
- category: Otologic
name: Congenital Profound Sensorineural Hearing Loss
frequency: OBLIGATE
severity: SEVERE
description: >-
Bilateral, symmetric and profound from birth, and non-progressive - a point of
contrast with most dominant hereditary hearing losses and with the dominant RIPOR2
disorder in particular.
phenotype_term:
preferred_term: Profound sensorineural hearing impairment
term:
id: HP:0011476
label: Profound sensorineural hearing impairment
clinical_course: STABLE
evidence:
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In a large consanguineous Turkish kindred with recessive nonsyndromic, prelingual,
profound hearing loss, we identified in the gene FAM65B (MIM611410) a splice site
mutation (c.102-1G>A) that perfectly cosegregates with the phenotype in the family.
explanation: >-
Establishes the severity and the prelingual onset in the founding family.
- category: Otologic
name: Prelingual Onset
frequency: OBLIGATE
phenotype_term:
preferred_term: Prelingual sensorineural hearing impairment
term:
id: HP:0000399
label: Prelingual sensorineural hearing impairment
description: >-
Onset before speech acquisition, which is what makes early habilitation the whole of
the clinical management question in this disease.
evidence:
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In a large consanguineous Turkish kindred with recessive nonsyndromic, prelingual,
profound hearing loss, we identified in the gene FAM65B (MIM611410) a splice site
mutation (c.102-1G>A) that perfectly cosegregates with the phenotype in the family.
explanation: >-
States the onset directly.
- category: Otologic
name: Bilateral Involvement
frequency: OBLIGATE
phenotype_term:
preferred_term: Bilateral sensorineural hearing impairment
term:
id: HP:0008619
label: Bilateral sensorineural hearing impairment
evidence:
- reference: PMID:37864412
reference_title: "RIPOR2: A new gene of non-syndromic cochleovestibular dysfunction, discrepancy between human pathology and animal models."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
in RIPOR2 (RHO family interacting cell polarization regulator 2) has been identified
by WES in Tunisian siblings suffering from congenital bilateral profound hearing and
vestibular dysfunctions.
explanation: >-
States the hearing loss is bilateral and congenital.
- category: Otologic
name: Vestibular Areflexia
frequency: OCCASIONAL
description: >-
Present in the Tunisian siblings, absent in the Turkish kindred. Curated as OCCASIONAL
on the strength of one family out of two rather than on a measured frequency, and read
alongside the knowledge gap on allele specificity below.
phenotype_term:
preferred_term: Vestibular areflexia
term:
id: HP:0008568
label: Vestibular areflexia
evidence:
- reference: PMID:37864412
reference_title: "RIPOR2: A new gene of non-syndromic cochleovestibular dysfunction, discrepancy between human pathology and animal models."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In contrast to the vestibular areflexia observed in our patients, deaf Ripor2 KO
mouse model and our zebrafish model have normal vestibular function.
explanation: >-
Names the areflexia in the patients, and in the same sentence the model discrepancy
that the discussion below is about.
genetic:
- name: RIPOR2
relationship_type: CAUSATIVE
variant_origin: GERMLINE
gene_term:
preferred_term: RIPOR2
term:
id: hgnc:13872
label: RIPOR2
association: >-
Biallelic loss-of-function variants in RIPOR2 cause DFNB104. The gene-disease claim
rests on perfect cosegregation in a large consanguineous Turkish kindred, functional
demonstration that the mutant protein fails to reach the plasma membrane, expression
of the wild-type protein in the right cells at the right developmental stages, and
loss of hair cells on knockdown in zebrafish - all in the founding report - with an
unrelated Tunisian family and a second allele added later.
RIPOR2 is also a dominant deafness gene, and that is a separate disease. A heterozygous
12-nucleotide in-frame deletion causes adult-onset progressive hearing loss and is a
frequent, highly penetrant founder allele in the Netherlands. Variant class and
zygosity, not the gene, decide which disease a patient has.
evidence:
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We conclude that FAM65B is a plasma membrane-associated protein of hair cell
stereocilia that is essential for hearing.
explanation: >-
The gene-function conclusion of the founding report.
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
In zebrafish, knockdown of fam65b leads to significant reduction of numbers of
saccular hair cells and neuromasts and to hearing loss.
explanation: >-
The independent functional support for the gene, from a model organism rather than
from the family.
- reference: PMID:32631815
reference_title: "A RIPOR2 in-frame deletion is a frequent and highly penetrant cause of adult-onset hearing loss."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Our study expands the phenotypic spectrum associated with RIPOR2 defects which had
so far only been described to underlie early-onset recessively inherited HL.
explanation: >-
Curated on the gene rather than on any phenotype node: it establishes that RIPOR2
carries two distinct diseases, and confirms from the outside that the recessive,
early-onset one is the disease this entry describes.
inheritance:
- name: Autosomal recessive
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
description: >-
Both reported families are consanguineous and both affected sibships are homozygous;
heterozygous relatives are unaffected for this phenotype. Consanguinity is not
incidental here - it is how two private alleles came to be homozygous at all, and it
is why the reported families come from populations where consanguineous marriage is
common rather than from anywhere the gene is enriched.
evidence:
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In a large consanguineous Turkish kindred with recessive nonsyndromic, prelingual,
profound hearing loss, we identified in the gene FAM65B (MIM611410) a splice site
mutation (c.102-1G>A) that perfectly cosegregates with the phenotype in the family.
explanation: >-
Recessive inheritance with cosegregation, in a consanguineous kindred.
animal_models:
- name: Fam65b/Ripor2 knockout mouse
species: Mouse
genotype: Fam65b (Ripor2) constitutive knockout, homozygous
publication: PMID:27269051
description: >-
The homozygous null mouse, which matches the biallelic human genotype in kind. It is
the source of essentially everything known about how RIPOR2 works: the taper ring,
the taperin dependency, the RhoC interaction, and the observation that stereocilia
develop before they deteriorate.
modeled_mechanisms:
- target: Disorganisation of the Taper Compartment
relationship: RECAPITULATES
fidelity: HIGH
description: >-
Loss of the RIPOR2 ring, with disruption of taperin's dense-core structure at the
same site.
limitations: >-
A constitutive null, whereas the Turkish human allele produces a mislocalised
protein. Whether a mislocalised product is inert or mildly interfering is not
addressed by a knockout.
readouts:
- name: Taperin dense-core structure at the stereociliary taper
target: Disorganisation of the Taper Compartment
direction: ALTERED
interpretation: >-
Taperin's organisation at the taper is disrupted in the absence of Fam65b,
establishing the compartment-level defect.
evidence:
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Taperin, a second protein near the taper, forms a dense-core-like structure that
is disrupted in the absence of Fam65b.
explanation: >-
The imaging result behind this readout.
evidence:
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Using biochemistry and stochastic optical reconstruction microscopy (STORM), we
show here that Fam65b oligomers form a circumferential ring near the basal taper
of the mechanically sensitive stereocilia of murine hair cells.
explanation: >-
Supports the model as the system in which the taper mechanism was defined.
- target: Mechanotransduction Failure
relationship: RECAPITULATES
fidelity: HIGH
description: >-
Mechanotransduction is affected in the knockout, and stereocilia deteriorate after
beginning to develop.
limitations: >-
Mouse hair cell transduction is measured directly; the human equivalent is inferred
from profound congenital deafness with no cochlear malformation, so the two are
linked by argument rather than by a shared measurement.
readouts:
- name: Hair cell mechanotransduction and stereocilia integrity
target: Mechanotransduction Failure
direction: DECREASED
interpretation: >-
Transduction is impaired and stereocilia deteriorate despite normal initiation of
development.
evidence:
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Stereocilia of Fam65b-deficient murine hair cells start to develop, but
mechanotransduction is affected and stereocilia deteriorate.
explanation: >-
Both halves of the readout in one sentence: function and structure.
evidence:
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Our findings thus reveal a highly organized compartment near the base of
stereocilia that is critical for hair cell function and affected in disease.
explanation: >-
The authors' own statement linking the model's compartment to human disease.
- target: Loss of RIPOR2 from the Stereociliary Taper
relationship: RESCUES
fidelity: HIGH
description: >-
Putting Fam65b back into deficient hair cells after birth restores the bundle, which
is the closest thing this disease has to a proof that the protein's absence is what
causes the structural defect rather than something downstream of a developmental
programme that has already gone wrong.
The rescue is also RhoC-dependent: a Fam65b construct that cannot bind RhoC fails to
rescue, which is what ties the taper mechanism to the GTPase rather than leaving
the interaction as a correlation.
limitations: >-
Re-expression by injectoporation into cochlear explants prepared at postnatal day 2
and cultured for two days, scored on bundle morphology. That is an ex vivo
preparation, which is why this link's evidence is typed IN_VITRO rather than
MODEL_ORGANISM even though it sits under `animal_models`. It says nothing about whether an equivalent intervention is
deliverable in a human cochlea, or about a timepoint after which the bundle can no
longer be restored.
readouts:
- name: Stereocilia morphology after Fam65b re-expression
target: Loss of RIPOR2 from the Stereociliary Taper
direction: RESTORED
interpretation: >-
Bundle defects are rescued by wild-type Fam65b but not by the RhoC-binding-deficient
construct, separating the structural requirement from the protein's mere presence.
evidence:
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Note morphological defects of stereocilia were rescued by Fam65b-GFP but not by
Fam65bRL/AA-GFP.
explanation: >-
The rescue and its RhoC-binding-dependent control in one result.
evidence:
- reference: PMID:27269051
reference_title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
The acute rescue of hair cell morphology by re-expression of Fam65b at postnatal
ages also suggests that defects in hair bundle morphology are likely not a
secondary consequence of perturbations in an overall developmental program but are
more specifically linked to a role of Fam65b in stereocilia.
explanation: >-
The authors' own reading of what the rescue establishes: a direct structural role
rather than a developmental knock-on. That is what makes the model a rescue system
for this node.
- target: Vestibular End-Organ Dysfunction
relationship: FAILS_TO_RECAPITULATE
fidelity: LOW
description: >-
The knockout mouse is deaf but vestibularly normal, while the Tunisian patients have
vestibular areflexia. The negative result is recorded because it is the substance of
this entry's model-mismatch discussion, not an incidental difference.
limitations: >-
The mouse is a constitutive null and the patients carry a nonsense allele, so the
comparison is close but not exact; and the discrepancy is reported by a paper whose
own zebrafish model behaves like the mouse, which strengthens the observation rather
than explaining it. Paralogue compensation has been proposed and not tested.
evidence:
- reference: PMID:37864412
reference_title: "RIPOR2: A new gene of non-syndromic cochleovestibular dysfunction, discrepancy between human pathology and animal models."
supports: REFUTE
evidence_source: MODEL_ORGANISM
snippet: >-
In contrast to the vestibular areflexia observed in our patients, deaf Ripor2 KO
mouse model and our zebrafish model have normal vestibular function.
explanation: >-
REFUTE against the proposition that the mouse reproduces the human vestibular
phenotype - which is exactly what FAILS_TO_RECAPITULATE asserts.
- name: Ripor2 knockout mouse (hair bundle morphogenesis)
species: Mouse
genotype: Ripor2 knockout, homozygous
publication: PMID:30280293
description: >-
The same null genotype studied for bundle orientation rather than taper
ultrastructure, and the source of the Myh9 route.
modeled_mechanisms:
- target: Hair Bundle Malformation and Misorientation
relationship: RECAPITULATES
fidelity: MODERATE
description: >-
Misoriented hair bundles during morphogenesis, aberrant kinocilium placement, and
reduced Myh9 protein despite increased transcript.
limitations: >-
MODERATE because bundle orientation has not been examined in human RIPOR2 tissue and
cannot be - the inner ear is not biopsied - so the human counterpart of this
structural readout is unobserved rather than confirmed.
readouts:
- name: Cochlear Myh9 protein abundance
target: Hair Bundle Malformation and Misorientation
direction: DECREASED
interpretation: >-
Myh9 protein falls in the Ripor2-null cochlea while its transcript rises,
identifying a post-transcriptional dependency.
evidence:
- reference: PMID:30280293
reference_title: "Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Absence of Ripor2 is associated with low Myh9 abundance in the mouse cochlea
despite increased amount of Myh9 transcripts.
explanation: >-
The measurement, with the transcript comparison that makes it interpretable.
evidence:
- reference: PMID:30280293
reference_title: "Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Here, we demonstrate that during the morphogenesis of the hair cell bundle,
absence of Ripor2 affects the orientation of this key subcellular structure.
explanation: >-
Supports the model as informative for the bundle-morphogenesis node.
- name: fam65b zebrafish morphant
species: Zebrafish
genotype: fam65b morpholino knockdown
publication: PMID:24958875
description: >-
Knockdown in zebrafish, used in the founding report as independent functional support
for the gene. It reduces saccular hair cell and neuromast numbers and impairs hearing.
modeled_mechanisms:
- target: Congenital Profound Sensorineural Hearing Loss
relationship: PARTIALLY_RECAPITULATES
fidelity: LOW
description: >-
Reproduces hearing loss on knockdown, alongside a loss of hair cells.
limitations: >-
A morpholino knockdown rather than a genetic null, in a species whose hair cells
regenerate and whose lateral line has no human counterpart. The hair cell loss also
goes further than the mouse phenotype, where cells are present but their bundles
deteriorate - so the two models disagree on whether cells die, and neither
observation has a human correlate.
evidence:
- reference: PMID:24958875
reference_title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
In zebrafish, knockdown of fam65b leads to significant reduction of numbers of
saccular hair cells and neuromasts and to hearing loss.
explanation: >-
PARTIAL because knockdown supports gene function in hearing without modelling the
human allele or its cellular consequence.
diagnosis:
- name: Comprehensive Hearing Loss Gene Panel or Exome Sequencing
description: >-
DFNB104 is clinically indistinguishable from the many other causes of congenital
profound nonsyndromic deafness, so it is found by sequencing rather than by
phenotyping. Both reported families were solved by exome sequencing in a consanguineous
pedigree, where homozygosity mapping narrows the search substantially.
evidence:
- reference: PMID:37864412
reference_title: "RIPOR2: A new gene of non-syndromic cochleovestibular dysfunction, discrepancy between human pathology and animal models."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
in RIPOR2 (RHO family interacting cell polarization regulator 2) has been identified
by WES in Tunisian siblings suffering from congenital bilateral profound hearing and
vestibular dysfunctions.
explanation: >-
Names the diagnostic method used in the second family.
- name: Vestibular Function Testing
description: >-
Worth doing in a RIPOR2 patient rather than assuming the deafness is isolated. The
Tunisian siblings' vestibular involvement was characterised by cervical VEMP and video
head-impulse testing; the Turkish kindred, assessed clinically, had no balance
problems. Whether the difference is real or a difference in how hard anyone looked is
the open question below.
evidence:
- reference: PMID:37864412
reference_title: "RIPOR2: A new gene of non-syndromic cochleovestibular dysfunction, discrepancy between human pathology and animal models."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In contrast to the vestibular areflexia observed in our patients, deaf Ripor2 KO
mouse model and our zebrafish model have normal vestibular function.
explanation: >-
Documents that vestibular function was formally assessed in these patients and what
it showed, which is the argument for testing rather than assuming - and, in the same
sentence, why the animal data cannot substitute for the test.
treatments:
- name: Cochlear Implantation
therapeutic_modality: DEVICE
treatment_term:
preferred_term: cochlear device implantation
term:
id: NCIT:C15329
label: Surgical Procedure
qualifiers:
- predicate:
preferred_term: medical device
term:
id: NCIT:C16830
label: Medical Device
value:
preferred_term: cochlear implant
term:
id: NCIT:C157820
label: Cochlear Implant
description: >-
The standard intervention for congenital profound sensorineural hearing loss, and the
only one that addresses the phenotype. The mechanism supports it in principle: the
lesion is in the hair cell bundle, upstream of the spiral ganglion that an implant
stimulates, and no cochlear structural malformation has been described in this
disease.
No outcome data exist for RIPOR2 patients specifically. Recorded without an evidence
item rather than with a quote from the general cochlear-implant literature, which
would not be about this disease.
target_mechanisms:
- target: Mechanotransduction Failure
treatment_effect: BYPASSES
description: >-
Bypasses the failed transduction step by stimulating the auditory nerve directly.
notes: >-
Carries no evidence item deliberately. The published RIPOR2 literature reports no
implant outcomes; the mechanistic rationale above is this entry's inference and is
labelled as such.
The treatment term is the generic surgical action, which is what implantation is.
NCIT:C157820 `Cochlear Implant` names the device rather than a clinical action and
is not reachable from NCIT:C25218, so it cannot be the `term:` of a TreatmentTerm.
The specificity is carried by `preferred_term`, and the device itself is attached
as a qualifier so it stays queryable rather than surviving only as free text. An
earlier version bound NCIT:C15315 Rehabilitation and cited
Jervell_and_Lange-Nielsen_Syndrome_1.yaml as the convention; that entry has been
corrected to the surgical term too.
- name: Early Identification and Habilitation
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: auditory habilitation
term:
id: NCIT:C15315
label: Rehabilitation
description: >-
Because the loss is prelingual and profound, the outcome that is actually modifiable
is spoken-language development, and the modifier is how early the loss is identified
and habilitated. Newborn hearing screening detects it. As with implantation, there are
no disease-specific data.
notes: >-
No evidence item, for the same reason as above. This is general practice for congenital
profound deafness, not a RIPOR2 finding.
- name: Vestibular Rehabilitation
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: vestibular rehabilitation
term:
id: NCIT:C15302
label: Physical Therapy
description: >-
Relevant only to the subgroup with vestibular involvement. Congenital bilateral
vestibular areflexia is compensated for by vision and proprioception rather than
recovered from, and balance training targets that compensation. As with the auditory
interventions there are no RIPOR2-specific data; this is standard practice for
bilateral vestibular loss.
target_mechanisms:
- target: Vestibular End-Organ Dysfunction
treatment_effect: BYPASSES
description: >-
Does not act on the mechanism. It trains substitute sensory strategies around a
deficit that remains.
notes: >-
No evidence item. Nothing in the RIPOR2 literature reports vestibular rehabilitation
outcomes, and the delayed independent walking documented in the affected siblings is
in the paper's full text rather than its cached abstract, so it is not quotable here.
- name: Genetic Counselling
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: genetic counseling
term:
id: NCIT:C15240
label: Genetic Counseling
description: >-
Autosomal recessive inheritance with a 25% recurrence risk per pregnancy for carrier
couples. Both reported families are consanguineous, which raises the prior for a
recessive cause in a similar family and makes carrier testing of at-risk relatives
worth offering.
differential_diagnoses:
- name: RIPOR2-related autosomal dominant hearing loss (DFNA21)
description: >-
The allelic dominant disorder, and the entity most likely to be confused with this one
because it is the same gene. A heterozygous 12-nucleotide in-frame deletion causes
adult-onset progressive hearing loss, segregating dominantly in twelve Dutch families
and highly penetrant. It is common enough in the southeast Netherlands to be found in
people not selected for hearing loss at all, which is the opposite epidemiological
situation from the private recessive alleles of DFNB104.
distinguishing_features:
- Heterozygous in-frame deletion rather than biallelic loss of function
- Adult onset, with a mean around the fourth decade, rather than congenital
- Progressive rather than stable
- A frequent founder allele in one population rather than a family-private variant
evidence:
- reference: PMID:32631815
reference_title: "A RIPOR2 in-frame deletion is a frequent and highly penetrant cause of adult-onset hearing loss."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
An in-frame deletion of 12 nucleotides in RIPOR2 was identified as a highly
penetrant cause of adult-onset progressive hearing loss that segregated as an
autosomal dominant trait in 12 families from the Netherlands.
explanation: >-
The dominant disorder in full - allele, onset, course and inheritance - every one of
which differs from this entry's disease.
- reference: PMID:32631815
reference_title: "A RIPOR2 in-frame deletion is a frequent and highly penetrant cause of adult-onset hearing loss."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Our study expands the phenotypic spectrum associated with RIPOR2 defects which had
so far only been described to underlie early-onset recessively inherited HL.
explanation: >-
States that the two RIPOR2 phenotypes are distinct, and that the recessive
early-onset one came first.
- name: Usher syndrome
description: >-
Relevant only for the family with vestibular involvement. Congenital profound deafness
with vestibular areflexia is the classic type 1 Usher presentation, so a RIPOR2 patient
with that combination can be mistaken for one until the retina is examined and found
normal. There is no retinitis pigmentosa in DFNB104.
distinguishing_features:
- No retinitis pigmentosa or other retinal degeneration
- Biallelic RIPOR2 variants rather than variants in an Usher gene
discussions:
- discussion_id: mismatch_vestibular_phenotype
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- pathophysiology#Vestibular End-Organ Dysfunction
- animal_models#Fam65b/Ripor2 knockout mouse
prompt: >-
Why do RIPOR2-null mice and zebrafish have normal vestibular function when human
patients with a homozygous RIPOR2 nonsense allele have vestibular areflexia?
rationale: >-
This is a mismatch rather than a gap: the model evidence exists and is clear, and it
disagrees with the patients. The mouse knockout is deaf with normal vestibular
function, and a zebrafish model behaves the same way, while the Tunisian siblings have
documented vestibular areflexia with abnormal cervical VEMPs and video head-impulse
testing. The paper reporting the patients names the discrepancy in its own title.
It matters because the mouse is the whole mechanistic account of this disease. Every
claim in the pathophysiology section above about the taper ring, taperin, RhoC and
Myh9 comes from an animal in which one of the two affected end organs behaves
normally. If the vestibular epithelium can tolerate RIPOR2 loss in mouse but not in
human, the mouse cochlear mechanism cannot be assumed to transfer without checking.
A specific hypothesis is available: RIPOR1 and RIPOR3 are close paralogues, and
compensation by them in the mouse vestibular epithelium could mask the phenotype.
Nobody has tested it, and an alternative - that human vestibular hair cells depend
more heavily on the taper compartment than mouse ones do - would have quite different
implications for reading the rest of the mouse data.
proposed_experiments:
- experiment_id: ripor_paralogue_expression_vestibular
name: Paralogue expression and compensation in mouse versus human vestibular epithelium
description: >-
Compare RIPOR1, RIPOR2 and RIPOR3 expression across cochlear and vestibular hair
cells in mouse and in human inner ear tissue, then test whether removing the
paralogues alongside Ripor2 in mouse vestibular hair cells unmasks a vestibular
phenotype.
would_support:
- pathophysiology#Vestibular End-Organ Dysfunction
supporting_outcome:
- >-
Paralogue expression is higher in mouse vestibular hair cells than in the human
equivalent, and combined removal produces vestibular dysfunction in mouse - which
would make the mismatch a compensation artefact and leave the cochlear mechanism
transferable.
refuting_outcome:
- >-
Paralogue expression is comparable across species and combined removal leaves
vestibular function intact, which would point to a genuine species difference in how
the taper compartment is used and would weaken the case for reading any of the mouse
mechanism straight across.
- discussion_id: gap_allele_specific_vestibular
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- phenotypes#Vestibular Areflexia
- genetic#RIPOR2
prompt: >-
Is the vestibular phenotype specific to the nonsense allele, or was it simply not
looked for in the first family?
rationale: >-
The two reported families differ on vestibular involvement and also differ on allele
class and on how vestibular function was assessed. The Turkish kindred was reported as
having no balance problems on clinical assessment; the Tunisian siblings were
characterised with cervical VEMPs and video head-impulse testing, which detect
dysfunction that a clinical balance history does not.
So there are at least three live readings - an allele-specific effect, a
genetic-background effect, and an ascertainment difference - and two families cannot
distinguish them. The practical stake is whether to counsel a newly diagnosed RIPOR2
patient about vestibular involvement, and whether to test for it.
proposed_experiments:
- experiment_id: vestibular_testing_all_ripor2_families
name: Uniform vestibular testing across all reported and newly ascertained RIPOR2 families
description: >-
Apply the same vestibular battery - cervical and ocular VEMPs, video head-impulse
testing, and developmental motor milestones - to affected individuals from both
published recessive families and any newly ascertained ones, and record the result
against allele class.
would_support:
- phenotypes#Vestibular Areflexia
supporting_outcome:
- >-
Formal testing finds vestibular dysfunction in splice-allele patients too, making
vestibular involvement part of the disease rather than an allele-specific feature.
refuting_outcome:
- >-
Splice-allele patients test normal on the same battery, which would support a real
allele-specific difference and make variant class relevant to counselling.
notes: >-
Named entity check. RIPOR2 carries two hearing-loss diseases and the literature does not
always separate them in its titles. This entry is the recessive one - DFNB104, biallelic
loss of function, congenital, profound, stable. The dominant in-frame-deletion disorder
(adult-onset, progressive, a Dutch founder allele) is a different disease and is curated
only under differential diagnoses, where PMID:32631815 is cited for what it actually
reports. The one place that paper is cited outside that section is on the gene entry,
for its statement that the two phenotypes are distinct.
Gene symbol. RIPOR2 was formerly FAM65B, and the founding paper and the 2016 mouse work
both use the old symbol throughout. Snippets quote whichever symbol the source used;
the ontology binding is to the current one.
Model provenance. Every mechanistic claim in the pathophysiology section other than the
protein-mislocalisation result comes from mouse, and the evidence items are typed
MODEL_ORGANISM to keep that visible. Human inner ear tissue is not obtainable, so this
is not a curation shortcut that better sources would fix.
references:
- reference: PMID:24958875
title: "FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing."
- reference: PMID:27269051
title: "Murine Fam65b forms ring-like structures at the base of stereocilia critical for mechanosensory hair cell function."
- reference: PMID:30280293
title: "Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation."
- reference: PMID:37864412
title: "RIPOR2: A new gene of non-syndromic cochleovestibular dysfunction, discrepancy between human pathology and animal models."
- reference: PMID:32631815
title: "A RIPOR2 in-frame deletion is a frequent and highly penetrant cause of adult-onset hearing loss."
Overview: Autosomal Recessive Nonsyndromic Hearing Loss 104 (DFNB104), also designated Deafness, Autosomal Recessive 104, is a form of prelingual, congenital, profound sensorineural hearing loss caused by biallelic (homozygous or compound heterozygous) loss-of-function variants in RIPOR2 (formerly known as FAM65B), located on chromosome 6p22.3. The disorder was first mapped and the causal gene identified in 2014 by Diaz-Horta and colleagues in a large consanguineous Turkish kindred (Diaz-Horta et al. 2014, PNAS, PMID 24958875). RIPOR2 encodes a plasma-membrane-associated actin-cytoskeletal regulatory protein that localizes to the base of the stereocilia in cochlear (and vestibular) hair cells and is required for normal stereocilia bundle structure and maintenance.
Key Identifiers: - OMIM: #616515 (DFNB104); gene entry 611410 (RIPOR2) (OMIM 616515; OMIM 611410) - MONDO: MONDO:0014675 - MedGen (NCBI): C4225298 — "Autosomal recessive nonsyndromic hearing loss 104" (MedGen) - HGNC: HGNC:13872 (RIPOR2; formerly FAM65B) - Gene locus: 6p22.3 - Orphanet: Grouped under the generic "Autosomal recessive non-syndromic sensorineural deafness type DFNB" umbrella entries; a DFNB104-specific ORPHA code was not independently confirmed in primary Orphanet sources during this research and should be verified directly against Orphadata before citation. - ICD-10:* H90.3 (Sensorineural hearing loss, bilateral) — generic code; no disease-specific ICD-10/11 code exists for DFNB104.
Synonyms/Alternative Names: - DFNB104 - Deafness, Autosomal Recessive 104 - FAM65B-related deafness - RIPOR2-related nonsyndromic hearing loss (recessive form; distinct from the dominant RIPOR2-related DFNA21)
Data source note: All published information derives from aggregated disease-level resources — pedigree/cosegregation studies in a small number of consanguineous families (Turkish, Tunisian) — plus complementary murine and zebrafish model data, rather than large EHR-derived cohorts. This is consistent with an ultra-rare monogenic recessive deafness gene.
Important nomenclature distinction: RIPOR2 causes two clinically and genetically distinct hearing-loss entities: - DFNB104 — biallelic (recessive) loss-of-function variants → congenital, profound, non-progressive hearing loss (this report's focus). - DFNA21 — heterozygous, dominant-negative in-frame deletion (c.1696_1707del) → adult-onset, progressive hearing loss, described as a frequent Dutch founder variant (Oonk et al. 2020, PMID 32631815).
Disease Causal Factors: DFNB104 is purely genetic/monogenic — caused by biallelic loss-of-function (null or severely hypomorphic) variants in RIPOR2. No environmental, infectious, or multifactorial contribution has been reported.
Genetic Risk Factors: - Causal variants identified to date (small number of families): - c.102-1G>A (splice acceptor, intron 2) — homozygous in the original consanguineous Turkish family, causing in-frame skipping of exon 3 and deletion of residues 34–86 (p.R34_D86delinsS) within the core PX membrane-localization domain (Diaz-Horta et al. 2014, PMID 24958875). - c.189-1G>A (splice acceptor variant) — reported in ClinVar as pathogenic for DFNB104 (ClinVar RCV000190353). - c.1561C>T (p.Arg521) — homozygous nonsense variant identified in three Tunisian siblings with congenital profound hearing loss and* vestibular areflexia, the third reported RIPOR2 pathogenic allele and the first with a documented vestibular phenotype (Morel et al. 2023, Clinical Genetics, DOI 10.1111/cge.14436). - Consanguinity is a strong risk factor for exposing biallelic RIPOR2 variants, consistent with the Turkish and Tunisian consanguineous pedigrees in which the condition has been reported. - The mutation was absent from dbSNP, the Exome Variant Server, and 330 Turkish population controls in the original report, consistent with a rare, family-restricted (non-founder) allele in that population — in contrast to the common Dutch dominant founder deletion causing DFNA21.
Environmental Risk Factors: None identified; this is a purely Mendelian condition with no reported environmental modifiers of penetrance.
Protective Factors: None reported specific to RIPOR2/DFNB104. Speculative genetic compensation by paralogs RIPOR1 and RIPOR3 (~70% sequence similarity) has been proposed as a possible explanation for milder or absent vestibular phenotypes in some model systems, but this has not been demonstrated as a true protective mechanism in humans (Morel et al. 2023).
Gene-Environment Interactions: None documented; no CTD or GxE database entries were identified linking RIPOR2 to environmental modifiers.
No dedicated EQ-5D/SF-36/disease-specific QOL studies were identified for DFNB104 specifically. As with other forms of congenital profound sensorineural deafness, the expected impact includes impaired spoken-language acquisition without early intervention (hearing aids/cochlear implantation), and — in the vestibular-areflexia subset — additional impact on gross motor development and balance-dependent activities (data extrapolated from general profound-deafness and vestibular-areflexia literature; no RIPOR2-specific QOL instrument data located).
Causal Gene: RIPOR2 (RHO Family Interacting Cell Polarization Regulator 2), formerly FAM65B. - HGNC: HGNC:13872 - OMIM gene: 611410 - Locus: 6p22.3 - Ensembl:* ENSG00000111913
Pathogenic Variants (recessive, DFNB104): | Variant | Effect | Family/Population | Source | |---|---|---|---| | c.102-1G>A | Splice acceptor → exon 3 skipping, in-frame deletion of aa 34-86 (p.R34_D86delinsS), disrupting the PX membrane-localization domain | Consanguineous Turkish family (6 affected) | PMID 24958875 | | c.189-1G>A | Splice acceptor variant, pathogenic | ClinVar-reported | ClinVar RCV000190353 | | c.1561C>T (p.Arg521*) | Nonsense/premature stop, exon 14 | Consanguineous Tunisian family (3 affected siblings) | Morel et al. 2023, Clin Genet |
Protein structure/function: - RIPOR2/FAM65B contains a PX(-like)-BAR module region implicated in membrane targeting and curvature sensing (though a later PNAS letter disputed strict PX-BAR domain classification — PMID for "Little evidence that FAM65B belongs to the family of PX and BAR domain-containing proteins," PNAS 2014 — a caveat worth noting for structural claims). - RIPOR2 is an atypical inhibitor of the small GTPase RhoA, implicated (in non-auditory contexts) in myoblast fusion and leukocyte polarization/migration. - In hair cells, RIPOR2 forms circumferential ring-like oligomeric structures (~229 ± 7 nm diameter) at the basal taper of stereocilia, distinct from taperin's intra-stereociliary core localization; RhoC (not RhoA) co-localizes with and regulates RIPOR2 oligomerization in this compartment (Krey et al. 2016, eLife, PMID for "Murine Fam65b forms ring-like structures..."). - RIPOR2 interacts with MYH9 (a known deafness gene, DFNA17); loss of Ripor2 in mice is associated with reduced MYH9 protein abundance (despite increased transcript) and aberrant kinocilium localization during hair-bundle morphogenesis (Xiong et al. 2018, J Mol Med, PMID 30280293).
Suggested ontology terms: - Gene: hgnc:13872 (RIPOR2) - GO Molecular Function: GO:0005096 (GTPase activator activity) — for RhoA/RhoC-modulating activity; verify precise GO term at curation - GO Cellular Component: GO:0032420 (stereocilium), GO:0060091 (kinocilium) - GO Biological Process: GO:0032420-related stereocilium organization; GO:0060088 auditory receptor cell stereocilium organization
No environmental factors, lifestyle factors, or infectious agents have been implicated in DFNB104 causation — it is a fully penetrant monogenic recessive disorder. No CTD, TOXNET, or epidemiological database entries link RIPOR2/DFNB104 to environmental exposures.
Causal chain (upstream → downstream):
Note on module conformance (dismech context): This causal chain — stereociliary actin-cytoskeleton disruption → hair-bundle structural/mechanotransduction failure → profound congenital deafness — is mechanistically analogous to, but molecularly distinct from, the EPS8/EPS8L2 (DFNB102/DFNB106) pathway, which involves stereocilia elongation and maintenance via direct actin-bundling rather than RhoA/RhoC-regulated membrane-ring formation. If a "stereocilia structure/maintenance" mechanism module exists in dismech, DFNB104 nodes should specify the RIPOR2/RhoC/MYH9 axis distinctly from the EPS8/EPS8L2/actin-elongation axis.
Cellular processes involved: - Actin cytoskeleton organization/regulation (via Rho-family GTPase signaling) - Stereocilia bundle morphogenesis and maintenance - Mechanotransduction (sensory transduction in hair cells) - Possibly cell polarity establishment (kinocilium positioning)
Protein dysfunction: Loss of function via (a) failed membrane trafficking/localization (splice variant) or (b) truncation/nonsense-mediated decay (nonsense variant) — net effect is absence of functional RIPOR2 at the stereociliary base.
Biochemical abnormalities: Reduced MYH9 protein abundance despite normal/increased Myh9 transcript levels in Ripor2-null mouse cochlea — a post-transcriptional/protein-stability defect downstream of RIPOR2 loss.
Molecular profiling: No transcriptomic, proteomic, metabolomic, or single-cell/spatial datasets specific to human DFNB104 tissue were identified (expected, given the rarity of the condition and inaccessibility of human inner-ear tissue); mechanistic molecular data derive from mouse and zebrafish models.
Suggested GO terms: - GO:0060088 — auditory receptor cell stereocilium organization - GO:0035090 — maintenance of apical/basal cell polarity (if applicable to kinocilium positioning) - GO:0007266 — Rho protein signal transduction
Suggested CL terms: - CL:0000601 — inner hair cell - CL:0000602 — outer hair cell - CL:0000855 — sensory hair cell (general, if subtype not specified)
Organ level: - Primary organ: inner ear (cochlea) — auditory portion. - Secondary/variant-dependent involvement: vestibular labyrinth (semicircular canals, otolith organs) — affected in the Tunisian p.Arg521* family but not the original Turkish splice-variant family, indicating allele-dependent penetrance of the vestibular phenotype. - Body system: sensory/auditory-vestibular system (cranial nerve VIII pathway secondarily, via sensory input loss, not primary neuronal pathology).
Tissue and cell level: - Sensory epithelium of the organ of Corti (cochlea) — inner and outer hair cells (CL:0000601, CL:0000602). - Vestibular sensory epithelium (cristae ampullares, maculae) in variant-affected individuals.
Subcellular level: - Stereocilia — specifically the basal taper/base region where RIPOR2 forms its ring-like oligomeric structure (distinct from the stereocilia tips, where EPS8/EPS8L2 act). - Plasma membrane (site of normal RIPOR2 localization; site of failed trafficking for the mutant splice-variant protein). - Cytoplasmic inclusion bodies (site of pathological mutant-protein accumulation). - Kinocilium (secondarily mislocalized in Ripor2-deficient mice).
Localization: - Bilateral, symmetric involvement of both ears (consistent across all reported human cases). - No lateralization/asymmetry reported.
Suggested UBERON terms: - UBERON:0001846 — cochlea - UBERON:0002106 — spiral organ (organ of Corti) - UBERON:0002418 — stereocilium bundle / UBERON:0009866 stereocilium (verify precise term) - UBERON:0001838 — vestibular apparatus (for the variant-associated phenotype)
Suggested GO Cellular Component terms: - GO:0032420 — stereocilium - GO:0005886 — plasma membrane
Onset: Congenital/prelingual — hearing loss is present from birth or the earliest testable age (universal newborn hearing screening range), consistent with a developmental/structural stereociliary defect rather than a late degenerative process.
Onset pattern: Not acute or insidious in the usual sense — it is a static congenital deficit.
Progression: - Auditory phenotype: Non-progressive in the original (splice-variant) family — audiograms performed at multiple ages did not show worsening. This is a notable point of contrast with the RIPOR2-associated dominant DFNA21, which is explicitly progressive with average onset age 30.6 years (range 0–70 years) in the Dutch founder-variant cohort (PMID 32631815). - Vestibular phenotype (where present): Static congenital areflexia with developmental consequence (delayed independent walking at 21–24 months in the Tunisian siblings) rather than progressive vestibular decline.
Disease course pattern: Stable, chronic, lifelong sensorineural hearing loss.
Disease stages: Not formally staged (unlike some progressive conditions); severity is described simply as profound at diagnosis and remains profound.
Remission patterns: None — this is a structural/developmental sensory deficit with no spontaneous remission; management is via habilitation (hearing aids, cochlear implantation), not disease-modifying treatment.
Critical periods: As with all forms of prelingual profound deafness, early identification (newborn hearing screening) and early intervention (hearing aids/cochlear implant, before ~2–3 years of age) represent the critical window for optimizing spoken-language outcomes — a general principle for congenital SNHL, not RIPOR2-specific data.
Epidemiology:
- No population-level prevalence or incidence estimates exist for DFNB104 specifically; it is described only via individual case families (an ultra-rare, "cases in literature" level of epidemiological documentation — likely fewer than 10 families reported worldwide as of 2023–2024: 1 Turkish family with 6 affected, 1 Tunisian family with 3 affected, plus scattered additional ClinVar-reported variants of uncertain full clinical documentation).
- Suggested prevalence_class: NOT_YET_DOCUMENTED or CASES_IN_LITERATURE (per dismech's PrevalenceMeasureEnum), given the case-family-level evidence base.
Inheritance pattern: Autosomal recessive (biallelic variants required; heterozygous carriers are unaffected for DFNB104, in contrast to the dominant DFNA21 allele in the same gene).
Penetrance: Complete in all reported biallelic carriers (100% penetrance for the auditory phenotype across both reported families).
Expressivity: Variable — specifically regarding the vestibular component (present in the Tunisian p.Arg521* family, absent in the Turkish c.102-1G>A family), suggesting possible allele-specific or genetic-background-dependent expressivity. The auditory phenotype (profound, congenital, non-progressive) appears consistent across families.
Genetic anticipation: Not applicable/not reported (not a repeat-expansion disorder).
Germline mosaicism: Not reported in the literature reviewed.
Founder effects: Not established for the recessive DFNB104 alleles (each reported variant appears private to its family) — this contrasts with the well-characterized Dutch founder deletion causing the dominant DFNA21.
Consanguinity role: Central — both reported families (Turkish, Tunisian) are consanguineous, which is the mechanism by which rare private recessive alleles became biallelic and phenotypically manifest.
Carrier frequency: Not established in population databases (gnomAD) given the rarity/private nature of reported alleles.
Population demographics: - Reported affected families: Turkish (original discovery family) and Tunisian (second reported vestibular-affected family) — both from populations with documented elevated rates of consanguineous marriage, consistent with ascertainment bias toward populations where recessive conditions are more readily unmasked and studied. - No broader geographic/ethnic prevalence data available. - Sex ratio: Autosomal recessive — expected 1:1 male:female; no skew reported (consistent with the 6 and 3 affected individuals reported, though gender breakdown was not the emphasized detail in these papers).
Clinical/audiological tests: - Auditory brainstem response (ABR): absent, consistent with profound SNHL. - Otoacoustic emissions (OAE): absent/negative. - Acoustic reflex testing: absent. - Pure-tone audiometry: profound bilateral symmetric SNHL. - Vestibular testing (where indicated): cervical VEMPs (abnormal in Tunisian family), video head-impulse test (vHIT) — negative gains, covert saccades on posterior/lateral canals in the vestibular-areflexia subgroup.
Genetic testing: - Recommended approach: Given DFNB104's genetic and phenotypic overlap with dozens of other DFNB loci (e.g., GJB2, MYO15A, OTOF, and the mechanistically related EPS8/EPS8L2/DFNB102/106), a multi-gene nonsyndromic hearing loss panel or exome sequencing (especially in consanguineous families, where autozygosity mapping/homozygosity-region analysis is powerful — as used in both the original Turkish and Tunisian discovery studies) is the standard diagnostic approach rather than single-gene RIPOR2 testing. - Whole exome sequencing (WES): Was the discovery method in both published families (combined with linkage/homozygosity mapping). - Gene panels: RIPOR2 is included in clinical "monogenic hearing loss" gene panels (e.g., Genomics England PanelApp lists RIPOR2 under its Monogenic hearing loss panel). - Chromosomal microarray/karyotyping/FISH: Not applicable — DFNB104 arises from sequence-level (not structural chromosomal) variants. - Mitochondrial DNA testing: Not applicable (nuclear gene).
Clinical criteria: No RIPOR2/DFNB104-specific diagnostic criteria exist beyond standard nonsyndromic hearing loss workup; diagnosis is genetically confirmed (biallelic pathogenic RIPOR2 variants in a proband with congenital nonsyndromic profound SNHL, especially with consanguinity or homozygosity by descent).
Differential diagnosis: - Other DFNB loci causing congenital profound nonsyndromic SNHL (GJB2/DFNB1, MYO15A/DFNB3, OTOF/DFNB9, TMC1/DFNB7/11, and many others). - Usher syndrome (if vestibular areflexia is present in an affected individual — must be distinguished from RP-associated Usher syndrome by absence of retinal/ophthalmologic findings, since the Tunisian RIPOR2 phenotype mimics a Usher-like cochleovestibular presentation without retinitis pigmentosa). - The mechanistically related but molecularly distinct EPS8-family disorders (DFNB102/EPS8, DFNB106/EPS8L2) — clinically distinguishable by their typically progressive (rather than congenital-stable) course.
Screening: Universal newborn hearing screening (standard of care generally, not RIPOR2-specific) would detect the congenital profound hearing loss; cascade genetic testing/carrier screening is relevant in consanguineous families with a known proband variant.
Survival/mortality: No excess mortality — DFNB104 is an isolated (nonsyndromic) sensory disorder with no reported systemic or life-limiting comorbidity.
Morbidity/function: - Primary morbidity is profound congenital deafness, with attendant impact on spoken-language development if unaddressed by early habilitation. - In the vestibular-areflexia subset (Tunisian family), additional morbidity includes delayed gross motor/balance milestones (delayed independent walking) and likely lifelong absence of the vestibulo-ocular reflex, which may affect balance in low-visual/proprioceptive-input conditions (e.g., darkness, uneven surfaces) — extrapolated from general vestibular-areflexia literature, not RIPOR2-specific outcome studies.
Disease course: Stable — the hearing loss does not progress further once established (a favorable prognostic feature relative to progressive DFNB/DFNA forms), meaning habilitative interventions (hearing aids, cochlear implants) are not expected to need escalation due to further hearing decline.
Complications: None specific reported beyond the sensory/developmental consequences above; cochlear implantation is expected to be effective given the absence of documented cochlear structural malformation beyond the stereociliary/hair-cell level (though implant-specific outcome data for RIPOR2/DFNB104 patients specifically were not identified in this search).
Prognostic factors: Early cochlear implantation/hearing amplification is the major modifiable prognostic factor for language outcomes, per general principles of congenital profound SNHL management (not RIPOR2-specific trial data).
No RIPOR2/DFNB104-specific gene therapy, pharmacotherapy, or targeted molecular treatment currently exists or is in registered clinical trials (no ClinicalTrials.gov entries or AAV inner-ear gene-therapy programs targeting RIPOR2 were identified in this search, in contrast to genes like OTOF, which has advanced AAV gene-therapy programs).
Standard of care (supportive/rehabilitative, non-gene-specific):
- Hearing amplification: Hearing aids for residual hearing (typically limited benefit given profound loss).
- NCIT term: NCIT:C15302 (Physical Therapy) is not correct; more appropriate would be a hearing-device/audiologic-rehabilitation NCIT term if available, or leave treatment_term free-text if no exact NCIT match exists (device-based interventions currently lack a precise NCIT clinical-action term per dismech's own documented gap for "DEVICE" modality).
- Cochlear implantation: The mainstay definitive intervention for congenital profound bilateral SNHL.
- NCIT: no exact single term found in this search; consider NCIT:C15329 (Surgical Procedure) as the treatment_term with device/implant specified in description, or search NCIT specifically for "Cochlear Implantation" at curation time.
- Vestibular rehabilitation (for the vestibular-areflexia subgroup): standard balance/vestibular physical therapy.
- NCIT:C15302 (Physical Therapy) applicable here.
- Genetic counseling: Recommended for consanguineous families with an identified proband, given the autosomal recessive inheritance and elevated recurrence risk (25% per pregnancy for carrier parents).
- NCIT:C15240 (Genetic Counseling).
Experimental/preclinical therapeutic direction (mechanistic rationale, not yet RIPOR2-specific): - Mouse model rescue experiments have shown that re-expression of Fam65b/Ripor2 in deficient hair cells can rescue mechanotransduction defects (Krey et al. 2016, eLife), providing proof-of-concept rationale for a future AAV-mediated gene-replacement approach analogous to those in advanced development for OTOF, TMC1, and other DFNB genes — but no RIPOR2-specific vector or preclinical inner-ear gene-therapy publication was identified as of this search.
Treatment outcomes: No RIPOR2-specific treatment-response, adverse-event, or comparative-effectiveness data located.
HUMAN_MODEL_MISMATCH discussion for dismech curation.Mouse models:
- Ripor2 (Fam65b) knockout mice: Complete deafness; hair bundle morphological defects (disorganized/misoriented stereocilia bundles), reduced mechanotransduction currents, aberrant kinocilium localization, and reduced MYH9 protein abundance in the cochlea (Xiong et al. 2018, J Mol Med, PMID 30280293; Krey et al. 2016, eLife).
- Phenotype recapitulation: High fidelity for the auditory phenotype (deafness, hair-bundle/stereocilia structural defects, mechanotransduction failure) — closely mirrors human DFNB104.
- Model limitation: Vestibular phenotype is NOT recapitulated — Ripor2-knockout mice show normal balance/vestibular function (no circling behavior), unlike the vestibular areflexia documented in at least one human family. This is an explicit, well-documented human-model mismatch meriting HUMAN_MODEL_MISMATCH classification (per dismech schema conventions) rather than a generic KNOWLEDGE_GAP, since the evidence (mouse vestibular testing) exists but its translational validity to the human vestibular phenotype is the open question. Proposed explanations in the primary literature include incomplete/insensitive vestibular testing in mice and genetic compensation by paralogs RIPOR1/RIPOR3.
- Rescue experiments: Re-expression of wild-type Fam65b/Ripor2 in deficient hair cells rescues mechanotransduction current defects, demonstrating causality and supporting the eventual therapeutic feasibility of gene replacement (eLife 2016).
Zebrafish models: - fam65b knockdown (morpholino) zebrafish: Significant reduction in saccular hair cell numbers and neuromasts, and hearing loss, reported in the original discovery paper (Diaz-Horta et al. 2014, PMID 24958875). - fam65b nonsense-mutant zebrafish (from the Tunisian-family follow-up study): No circling behavior or balance abnormality at 5 days post-fertilization, again showing the auditory-but-not-vestibular phenotype discrepancy relative to at least one human RIPOR2 family (Morel et al. 2023).
Applications: These models have been used to establish causality (loss-of-function → hearing loss), define the subcellular localization and oligomeric ring structure of RIPOR2 at the stereociliary base, dissect the RhoC-dependent regulatory mechanism, identify the MYH9 interaction, and demonstrate rescue of mechanotransduction by gene re-expression — the last providing direct preclinical proof-of-concept for a future gene-therapy approach.
Resources: MGI (Mouse Genome Informatics) for Ripor2 knockout allele records; ZFIN for zebrafish fam65b/ripor2 mutant/morphant lines (specific allele/stock IDs not retrieved in this search — recommend direct MGI/ZFIN query at curation time for exact resource identifiers).
| Citation | Key Contribution |
|---|---|
| Diaz-Horta O, et al. PNAS 2014. PMID: 24958875 | Discovery of FAM65B/RIPOR2 as DFNB104 gene; c.102-1G>A splice variant; Turkish family clinical/audiometric characterization; zebrafish knockdown model |
| Xiong W, et al. J Mol Med 2018. PMID: 30280293 | Ripor2 mouse knockout: hair-bundle structure/orientation defects; MYH9 interaction |
| Krey JF, et al. eLife 2016. DOI 10.7554/eLife.14222 | RIPOR2 ring-like stereociliary base structure; RhoC-dependent oligomerization; mechanotransduction rescue |
| Oonk AMM, et al. 2020. PMID: 32631815 | Dominant RIPOR2 founder deletion causing DFNA21 (adult-onset, progressive) — important nosological contrast to DFNB104 |
| Morel N, et al. Clin Genet 2023. DOI 10.1111/cge.14436 | Third RIPOR2 variant (p.Arg521*); Tunisian family with vestibular areflexia; explicit human-vs-animal-model vestibular-phenotype discrepancy discussion |
| OMIM #616515 | Clinical synopsis and molecular genetics summary for DFNB104 |
| OMIM *611410 | RIPOR2 gene entry |
Notable curation caveats for dismech entry construction:
1. The Orphanet-specific identifier for DFNB104 could not be independently confirmed in this research pass and should be verified directly against Orphadata/ORPHA before citation (avoid citing an unverified ORPHA code).
2. The PX-BAR domain structural classification for RIPOR2/FAM65B has been directly disputed in the literature (PNAS 2014 technical comment) — cite this nuance if describing protein domain structure in detail.
3. The vestibular phenotype is not uniform across reported DFNB104 families — this is a genuine expressivity finding, not an error, and should be modeled as such (e.g., via subtype-level or evidence-item-level distinction between the Turkish and Tunisian families) rather than collapsed into a single uniform phenotype claim.
4. No RIPOR2-specific prevalence, treatment-trial, or QOL data exist beyond the two published case families — this is an ultra-rare, "cases-in-literature" level disorder, and prevalence/epidemiology fields should be populated conservatively (e.g., CASES_IN_LITERATURE / NOT_YET_DOCUMENTED).